Join        Login             Stock Quote

Merck And BGI Initiate “Substantive” Relationship

 September 16, 2010 10:11 AM

Merck (NYSE: MRK) has signed a letter of intent with BGI (formerly the Beijing Genomics Institute) that will "initiate and develop a working relationship," according to the press release. However, citing anonymous sources, Bio-IT World says this innocuous wording greatly understates the depth of the collaboration, which it calls "substantive, wide-ranging and long-term."

Bio-IT World says the agreement is "the most significant partnership announced so far between China's BGI and a major pharmaceutical company." It notes that BGI is working diligently to attract customers to its new next-generation sequencing (NGS) facility in Hong Kong and its bioinformatics center in Shenzhen. The magazine says BGI offers "unparalleled" services.

Merck and BGI said they will use the "massive output of genomic information" to explore areas of mutual interest in healthcare research and discovery. They intend to collaborate on biomarker discovery, target validation and drug development, and they will formulate specific projects.

As part of the agreement, the two companies will establish offices near the other to facilitate their research.

BGI is in discussions with several other big pharma companies, according to Alex Wong, chief of BGI's Hong Kong operation.

Bio-IT World will publish an article later this month on BGI Hong Kong, and that is, presumably, the basis for their inside sources in the company.

Disclosure: none.

iOnTheMarket Premium


Comments Closed

rss feed

Latest Stories

article imageEmerging-Markets Stocks Took The Lead Last Week

Emerging-markets equities enjoyed a solid rise last week among the major asset classes, based on a set of read on...

article imageDoes Your Latest Investment Pass This Test?

On Wednesday, I sounded the alarm about the problems looming for some consumer staples stocks. In short, read on...

article imageIs The Slump In US Manufacturing Easing?

Yesterday’s November survey data from the Philadelphia Fed hints at the possibility that a stronger trend read on...

article imageMarket Potentially Facing Near Term Technical Headwinds

After the S&P 500 Index pullback on Thursday and Friday last week, the market's advance on Monday and read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.